THE PRESENCE OF DIAMIDINES IN MYELOMA CELLS AFTER TREATMENT WITH STILBAMIDINE AND 2-HYDROXYSTILBAMIDINE

被引：15
|
作者：
SNAPPER, I
SCHNEID, B
KURNICK, N
机构：
来源：
ACTA HAEMATOLOGICA | 1950年 / 3卷 / 3-4期
关键词：
D O I：
10.1159/000203568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 134
页数：6
相关论文
共 50 条
  • [31] AUTOLOGOUS STEM CELLS TRANSPLANTATION AFTER USE OF NOVEL AGENTS AS SALVAGE TREATMENT FOR PATIENTS WITH MULTIPLE MYELOMA RELAPSED AFTER FIRST AUTOGRAFT
    Donnini, I.
    Nozzoli, C.
    Di Gioia, M.
    Staderini, M.
    Antonioli, E.
    Bacchiarri, F.
    Guidi, S.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 177 - 178
  • [32] Bone marrow mesenchymal stromal cells retain their tumor-educated phenotype after treatment of multiple myeloma
    Chubar, A.
    Semenova, N.
    Kostroma, I.
    Gritsaev, S.
    Bessmeltsev, S.
    Kotova, A.
    Ivolgin, D.
    Enukashvily, N.
    CYTOTHERAPY, 2020, 22 (05) : S76 - S76
  • [33] Influence of heat treatment of casein in presence of reducing sugars on Zn solubility and Zn uptake by Caco-2 cells after in vitro digestion
    Seiquer, I
    Valverde, A
    Delgado-Andrade, C
    Navarro, MP
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2000, 56 (03) : 237 - 246
  • [34] The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment
    Rasmussen, T
    Jensen, L
    Johnsen, HE
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1075 - 1077
  • [35] Proteomics of Caco-2 cells after silver nanoparticle treatment
    Juling, S.
    Lichtenstein, D.
    Boehmert, L.
    Selve, S.
    Schuemann, M.
    Niedzwiecka, A.
    Thuenemann, A.
    Braeuning, A.
    Krause, E.
    Lampen, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S81 - S81
  • [36] Presence of Disseminated Tumor Cells after Adjuvant Chemotherapy in Breast Cancer and Disseminated Tumor Cells Monitoring during Secondary Adjuvant Treatment
    Synnestvedt, M.
    Borgen, E.
    Wist, E.
    Wiedswang, G.
    Weyde, K.
    Risberg, T.
    Kersten, C.
    Mjaaland, I.
    Vindi, L.
    Schirmer, C. B.
    Nesland, J. M.
    Naume, B.
    CANCER RESEARCH, 2011, 71
  • [37] Presence of high (≥10%) Ki67+myeloma cells is associated with CD117 -: Phenotype, abnormal chromosomes and agressive myeloma gene clusters, and portends a poor outcome after autotransplant.
    Lee, CK
    Barlogie, B
    Kang, SH
    Shaughnessy, J
    Zangari, M
    Fassas, A
    Epstein, J
    Van Rhee, F
    Thertulien, R
    Talamo, I
    Cottler-Fox, MH
    Anaissie, EJ
    Tricot, G
    BLOOD, 2003, 102 (11) : 682A - 682A
  • [38] Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma
    Hitomi Hosoya
    Mia Carleton
    Kailee Tanaka
    Brian Sworder
    Shriya Syal
    Bita Sahaf
    Alisha M. Maltos
    Oscar Silva
    Henning Stehr
    Vanna Hovanky
    George Duran
    Tian Zhang
    Michaela Liedtke
    Sally Arai
    David Iberri
    David Miklos
    Michael S. Khodadoust
    Surbhi Sidana
    David M. Kurtz
    Nature Communications, 16 (1)
  • [39] Combination treatment of ATRA and COX2 inhibitor induced synergistic therapeutic effects on myeloma stem cells
    Wang, Siqing
    Zangari, Maurizio
    Shi, Lei
    Xiong, Wei
    Zeng, Zhaoyang
    Cao, Thai
    Xu, Hongwei
    Johnsson, Birgitta
    Zhan, Fenghuang
    Tricot, Guido
    CANCER RESEARCH, 2009, 69
  • [40] GLYCOPROTEIN-BIOSYNTHESIS IN MYELOMA CELLS - CHARACTERIZATION OF NONGLYCOSYLATED IMMUNOGLOBULIN LIGHT CHAIN SECRETED IN PRESENCE OF 2-DEOXY-D-GLUCOSE
    EAGON, PK
    HEATH, EC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1977, 252 (07) : 2372 - 2383
12345